
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $210.7M | $320M | $367.3M | |
Revenue Growth (YoY) | -- | -- | -- | 51.89% | 14.75% | |
Cost of Revenues | -- | -- | $46.2M | $44M | $50.1M | |
Gross Profit | -- | -- | $164.5M | $276M | $317.1M | |
Gross Profit Margin | -- | -- | 78.09% | 86.25% | 86.35% | |
R&D Expenses | -- | -- | $42.6M | $50M | $63.3M | |
Selling, General & Admin | -- | -- | $159.2M | $166.4M | $222M | |
Other Inc / (Exp) | -- | -- | -$9M | -$5.1M | -$12.8M | |
Operating Expenses | -- | -- | $204.8M | $220M | $289.2M | |
Operating Income | -- | -- | -$40.3M | $56M | $27.9M | |
Net Interest Expenses | -- | -- | $5.3M | $6.9M | -- | |
EBT. Incl. Unusual Items | -- | -- | -$54.6M | $44.1M | $24.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $262K | $5.9M | -$44.2M | |
Net Income to Company | -- | -- | -$54.9M | $38.1M | $68.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$54.9M | $38.1M | $68.7M | |
Basic EPS (Cont. Ops) | -- | -- | -$5.89 | $1.26 | $2.85 | |
Diluted EPS (Cont. Ops) | -- | -- | -$5.89 | $1.26 | $2.56 | |
Weighted Average Basic Share | -- | -- | $9.3M | $30.2M | $24.1M | |
Weighted Average Diluted Share | -- | -- | $28.4M | $30.2M | $26.9M | |
EBITDA | -- | -- | -$34M | $62.7M | $36M | |
EBIT | -- | -- | -$40.3M | $56M | $27.9M | |
Revenue (Reported) | -- | -- | $210.7M | $320M | $367.3M | |
Operating Income (Reported) | -- | -- | -$40.3M | $56M | $27.9M | |
Operating Income (Adjusted) | -- | -- | -$40.3M | $56M | $27.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $57.7M | $82.3M | $84.6M | |
Revenue Growth (YoY) | -- | -- | -- | 42.7% | 2.73% | |
Cost of Revenues | -- | -- | $11.3M | $10.5M | $17.1M | |
Gross Profit | -- | -- | $46.4M | $71.8M | $67.5M | |
Gross Profit Margin | -- | -- | 80.5% | 87.23% | 79.79% | |
R&D Expenses | -- | -- | $11.7M | $13.6M | $18.1M | |
Selling, General & Admin | -- | -- | $34.9M | $41.3M | $51.2M | |
Other Inc / (Exp) | -- | -- | -$1.5M | -$1.7M | -$399K | |
Operating Expenses | -- | -- | $47.4M | $55.9M | $70.3M | |
Operating Income | -- | -- | -$942K | $15.9M | -$2.8M | |
Net Interest Expenses | -- | -- | $1.7M | $1.8M | -- | |
EBT. Incl. Unusual Items | -- | -- | -$4.1M | $12.4M | $483K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $166K | $3.1M | -$72K | |
Net Income to Company | -- | -- | -$4.3M | $9.3M | $555K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$4.3M | $9.3M | $555K | |
Basic EPS (Cont. Ops) | -- | -- | -$0.46 | $1.00 | $0.02 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.46 | $0.33 | $0.02 | |
Weighted Average Basic Share | -- | -- | $9.3M | $9.3M | $30.8M | |
Weighted Average Diluted Share | -- | -- | $28.4M | $28.4M | $33.2M | |
EBITDA | -- | -- | -$830K | $17.8M | -$638K | |
EBIT | -- | -- | -$2.4M | $15.9M | -$2.8M | |
Revenue (Reported) | -- | -- | $57.7M | $82.3M | $84.6M | |
Operating Income (Reported) | -- | -- | -$942K | $15.9M | -$2.8M | |
Operating Income (Adjusted) | -- | -- | -$2.4M | $15.9M | -$2.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $344.7M | $369.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $43.3M | $56.7M | |
Gross Profit | -- | -- | -- | $301.4M | $312.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $51.9M | $67.7M | |
Selling, General & Admin | -- | -- | -- | $172.7M | $231.9M | |
Other Inc / (Exp) | -- | -- | -$1.5M | -$5.3M | -$11.5M | |
Operating Expenses | -- | -- | -- | $228.6M | $303.6M | |
Operating Income | -- | -- | -- | $72.8M | $9.2M | |
Net Interest Expenses | -- | -- | $1.7M | $7M | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | $60.6M | $12.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $8.9M | -$47.4M | |
Net Income to Company | -- | -- | -- | $51.7M | $60M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | $51.7M | $60M | |
Basic EPS (Cont. Ops) | -- | -- | -- | $3.54 | $1.74 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | $1.77 | $1.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | $79.8M | $17.6M | |
EBIT | -- | -- | -- | $72.8M | $9.2M | |
Revenue (Reported) | -- | -- | -- | $344.7M | $369.5M | |
Operating Income (Reported) | -- | -- | -- | $72.8M | $9.2M | |
Operating Income (Adjusted) | -- | -- | -- | $72.8M | $9.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $57.7M | $82.3M | $84.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $11.3M | $10.5M | $17.1M | |
Gross Profit | -- | -- | $46.4M | $71.8M | $67.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $11.7M | $13.6M | $18.1M | |
Selling, General & Admin | -- | -- | $34.9M | $41.3M | $51.2M | |
Other Inc / (Exp) | -- | -- | -$1.5M | -$1.7M | -$399K | |
Operating Expenses | -- | -- | $47.4M | $55.9M | $70.3M | |
Operating Income | -- | -- | -$942K | $15.9M | -$2.8M | |
Net Interest Expenses | -- | -- | $1.7M | $1.8M | -- | |
EBT. Incl. Unusual Items | -- | -- | -$4.1M | $12.4M | $483K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $166K | $3.1M | -$72K | |
Net Income to Company | -- | -- | -$4.3M | $9.3M | $555K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$4.3M | $9.3M | $555K | |
Basic EPS (Cont. Ops) | -- | -- | -$0.46 | $1.00 | $0.02 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.46 | $0.33 | $0.02 | |
Weighted Average Basic Share | -- | -- | $9.3M | $9.3M | $30.8M | |
Weighted Average Diluted Share | -- | -- | $28.4M | $28.4M | $33.2M | |
EBITDA | -- | -- | -$830K | $17.8M | -$638K | |
EBIT | -- | -- | -$2.4M | $15.9M | -$2.8M | |
Revenue (Reported) | -- | -- | $57.7M | $82.3M | $84.6M | |
Operating Income (Reported) | -- | -- | -$942K | $15.9M | -$2.8M | |
Operating Income (Adjusted) | -- | -- | -$2.4M | $15.9M | -$2.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $17.8M | $62.6M | $349.3M | |
Short Term Investments | -- | -- | $27.7M | -- | $408K | |
Accounts Receivable, Net | -- | -- | $121.6M | $226.4M | $220.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $7.4M | $9.3M | $11.2M | |
Total Current Assets | -- | -- | $174.5M | $298.3M | $581.7M | |
Property Plant And Equipment | -- | -- | $3.8M | $2.5M | $2M | |
Long-Term Investments | -- | -- | $4.5M | $4.5M | $4.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | $8.8M | $12.8M | $16.2M | |
Other Long-Term Assets | -- | -- | $3.5M | $1.5M | $794K | |
Total Assets | -- | -- | $195.1M | $319.8M | $678.4M | |
Accounts Payable | -- | -- | $5.9M | $8.9M | $7.2M | |
Accrued Expenses | -- | -- | $4.9M | $6.4M | $3.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $103.4M | $88.8M | $80.1M | |
Total Current Liabilities | -- | -- | $143.9M | $198.2M | $204.2M | |
Long-Term Debt | -- | -- | $61.1M | $64.4M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $229.9M | $291.9M | $221.1M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -$126K | -- | -- | |
Common Equity | -- | -- | -$34.8M | $27.9M | $457.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$34.8M | $27.9M | $457.3M | |
Total Liabilities and Equity | -- | -- | $195.1M | $319.8M | $678.4M | |
Cash and Short Terms | -- | -- | $45.5M | $62.6M | $349.7M | |
Total Debt | -- | -- | $61.1M | $64.4M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $79.5M | $297.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | $206.4M | $206.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | $14.2M | $24.3M | |
Total Current Assets | -- | -- | -- | $300.1M | $528M | |
Property Plant And Equipment | -- | -- | -- | $2.4M | $15.2M | |
Long-Term Investments | -- | -- | -- | $4.5M | $4.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | $13.9M | $17.6M | |
Other Long-Term Assets | -- | -- | -- | $1.1M | $792K | |
Total Assets | -- | -- | -- | $322.1M | $639.3M | |
Accounts Payable | -- | -- | -- | $7.7M | $11.3M | |
Accrued Expenses | -- | -- | -- | $8.3M | $6.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $86.9M | $78M | |
Total Current Liabilities | -- | -- | -- | $181.7M | $196.5M | |
Long-Term Debt | -- | -- | -- | $65.3M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $278M | $238M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | $44.1M | $401.3M | |
Total Liabilities and Equity | -- | -- | -- | $322.1M | $639.3M | |
Cash and Short Terms | -- | -- | -- | $79.5M | $297.1M | |
Total Debt | -- | -- | -- | $65.3M | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$54.9M | $38.1M | $68.7M | |
Depreciation & Amoritzation | -- | -- | $6.3M | $6.7M | $8.1M | |
Stock-Based Compensation | -- | -- | $6.5M | $7M | $46.9M | |
Change in Accounts Receivable | -- | -- | -$34.5M | -$105.7M | $4.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$56.5M | $22.7M | $115.9M | |
Capital Expenditures | -- | -- | $8.3M | $8.2M | $10.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$35.7M | $19.7M | -$10.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $78.5M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$5.2M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$31.3M | |
Other Financing Activities | -- | -- | -$430K | -$664K | -$10.3M | |
Cash From Financing | -- | -- | $74M | $2.4M | $181.4M | |
Beginning Cash (CF) | -- | -- | $35.9M | $17.8M | $62.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$18.1M | $44.8M | $287.1M | |
Ending Cash (CF) | -- | -- | $17.8M | $62.6M | $349.7M | |
Levered Free Cash Flow | -- | -- | -$64.8M | $14.5M | $105.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$4.3M | $9.3M | $555K | |
Depreciation & Amoritzation | -- | -- | $1.6M | $1.9M | $2.2M | |
Stock-Based Compensation | -- | -- | $1.8M | $1.8M | $11.6M | |
Change in Accounts Receivable | -- | -- | $3.7M | $19.9M | $14.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $2.7M | $19.4M | $19.9M | |
Capital Expenditures | -- | -- | $1M | $2.5M | $5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | $9.5M | -$2.5M | -$5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$69.8M | |
Other Financing Activities | -- | -- | -- | -$1.8M | -$631K | |
Cash From Financing | -- | -- | $260K | $9K | -$67M | |
Beginning Cash (CF) | -- | -- | $17.8M | $62.6M | $349.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $12.4M | $16.9M | -$52.2M | |
Ending Cash (CF) | -- | -- | $30.3M | $79.5M | $297.5M | |
Levered Free Cash Flow | -- | -- | $1.7M | $16.9M | $14.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | $51.7M | $60M | |
Depreciation & Amoritzation | -- | -- | -- | $7M | $8.3M | |
Stock-Based Compensation | -- | -- | $1.8M | $7M | $56.7M | |
Change in Accounts Receivable | -- | -- | -- | -$89.5M | -$1.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | $39.4M | $116.4M | |
Capital Expenditures | -- | -- | $1M | $9.7M | $12.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | $7.7M | -$12.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$9.1M | |
Cash From Financing | -- | -- | -- | $2.1M | $114.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $49.2M | $218M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | $29.7M | $103.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$4.3M | $9.3M | $555K | |
Depreciation & Amoritzation | -- | -- | $1.6M | $1.9M | $2.2M | |
Stock-Based Compensation | -- | -- | $1.8M | $1.8M | $11.6M | |
Change in Accounts Receivable | -- | -- | $3.7M | $19.9M | $14.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $2.7M | $19.4M | $19.9M | |
Capital Expenditures | -- | -- | $1M | $2.5M | $5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | $9.5M | -$2.5M | -$5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$69.8M | |
Other Financing Activities | -- | -- | -- | -$1.8M | -$631K | |
Cash From Financing | -- | -- | $260K | $9K | -$67M | |
Beginning Cash (CF) | -- | -- | $17.8M | $62.6M | $349.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $12.4M | $16.9M | -$52.2M | |
Ending Cash (CF) | -- | -- | $30.3M | $79.5M | $297.5M | |
Levered Free Cash Flow | -- | -- | $1.7M | $16.9M | $14.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.